Merck immunotherapy drug shows promise in bladder cancer
September 29, 2014 at 05:00 AM EDT
MADRID, Sept 29 (Reuters) - Merck & Co's new immune system drug Keytruda has produced encouraging results in early tests against bladder cancer, according to a company-sponsored study, prompting the firm to prepare a clinical trial later this year.
